Fresenius SE & Co. KGaA
FRE.DEXETRA
Product information
What is Fresenius SE & Co. KGaA (FRE.DE)?
Fresenius SE & Co. KGaA is a healthcare group headquartered in Bad Homburg, Germany, and was founded in 1912. Its shares trade on the Xetra platform in Frankfurt under the ticker FRE. The company's legal form, KGaA, means a partnership limited by shares. The company belongs to the DAX 40 index.
The group's operations rest on the following businesses. Fresenius Kabi makes injectable drugs, generics, clinical nutrition, infusion therapies and biosimilars. Fresenius Helios runs hospitals in Germany under the Helios brand and in Spain under the Quirónsalud brand. The group also holds a stake in Fresenius Medical Care, which works in dialysis services; this company has been outside the group's consolidated structure since 2023.
Those following Fresenius stock typically watch drug supply and manufacturing conditions, hospital occupancy and tariff developments, regulation of healthcare spending and the course of the stake in Fresenius Medical Care. The Lzzo.com Fresenius page brings the euros price, a price chart and technical indicators together on one screen.
Sources: fresenius.com, dax-indices.com
- Name
- Fresenius SE & Co. KGaA
- Symbol
- FRE.DE
- Market
- Stocks
What to look for in the technical analysis of Fresenius SE & Co. KGaA
Moving averages help assess the trend and RSI helps assess momentum. Indicators are calculated from real history; when there is not enough history or the required candle fields are missing, the indicator is not calculated. Past results do not guarantee future performance.
Technical indicators
Calculated from observed daily candles (at least 201 observations). No intraday indicators. Indicators are descriptive, not a buy/sell recommendation.
Investment Return CalculatorWith observed closes over the past year
Loading historical prices…